

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K36 demethylation (GO:0070544) | 4.68750972 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.57529243 |
| 3 | histone H3-K9 methylation (GO:0051567) | 4.13928508 |
| 4 | histone H3-K9 modification (GO:0061647) | 4.07154339 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 3.67368203 |
| 6 | negative regulation of mast cell activation (GO:0033004) | 3.62606829 |
| 7 | cellular response to exogenous dsRNA (GO:0071360) | 3.58194576 |
| 8 | interferon-gamma production (GO:0032609) | 3.52486509 |
| 9 | activated T cell proliferation (GO:0050798) | 3.50205920 |
| 10 | protein K11-linked deubiquitination (GO:0035871) | 3.34556504 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34043763 |
| 12 | positive regulation of granulocyte differentiation (GO:0030854) | 3.29601917 |
| 13 | neural tube formation (GO:0001841) | 3.27096844 |
| 14 | rRNA catabolic process (GO:0016075) | 3.24947339 |
| 15 | negative regulation of telomere maintenance (GO:0032205) | 3.13821472 |
| 16 | defense response to protozoan (GO:0042832) | 3.12506445 |
| 17 | basic amino acid transport (GO:0015802) | 3.10229067 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.07143987 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.07143987 |
| 20 | regulation of T cell tolerance induction (GO:0002664) | 3.04786264 |
| 21 | dosage compensation (GO:0007549) | 3.04258034 |
| 22 | regulation of mast cell activation (GO:0033003) | 3.00576388 |
| 23 | response to protozoan (GO:0001562) | 3.00255028 |
| 24 | protein K63-linked deubiquitination (GO:0070536) | 2.99353402 |
| 25 | regulation of T cell cytokine production (GO:0002724) | 2.98631100 |
| 26 | histone H3-K4 trimethylation (GO:0080182) | 2.95840414 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94494048 |
| 28 | positive regulation of mast cell activation (GO:0033005) | 2.94174343 |
| 29 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.92442216 |
| 30 | granulocyte differentiation (GO:0030851) | 2.90758038 |
| 31 | positive regulation of defense response to virus by host (GO:0002230) | 2.89397107 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87469041 |
| 33 | negative thymic T cell selection (GO:0045060) | 2.85139355 |
| 34 | negative regulation of interleukin-6 production (GO:0032715) | 2.82497031 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 2.81592850 |
| 36 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.81344292 |
| 37 | positive regulation of protein homooligomerization (GO:0032464) | 2.78612330 |
| 38 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.77500485 |
| 39 | necrotic cell death (GO:0070265) | 2.76597784 |
| 40 | maintenance of protein location in nucleus (GO:0051457) | 2.74454144 |
| 41 | negative T cell selection (GO:0043383) | 2.73029973 |
| 42 | regulation of tolerance induction (GO:0002643) | 2.71132853 |
| 43 | tryptophan metabolic process (GO:0006568) | 2.70863128 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70216574 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 2.69755012 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 2.69264736 |
| 47 | histone H4-K16 acetylation (GO:0043984) | 2.68937084 |
| 48 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.68613267 |
| 49 | regulation of T cell mediated immunity (GO:0002709) | 2.66555197 |
| 50 | erythrocyte development (GO:0048821) | 2.64782789 |
| 51 | programmed necrotic cell death (GO:0097300) | 2.63944448 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62294370 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 2.62294370 |
| 54 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62294370 |
| 55 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62294370 |
| 56 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62294370 |
| 57 | modulation by symbiont of host immune response (GO:0052553) | 2.62294370 |
| 58 | behavioral response to nicotine (GO:0035095) | 2.61749897 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61407761 |
| 60 | positive regulation by host of viral transcription (GO:0043923) | 2.59679316 |
| 61 | protein K48-linked deubiquitination (GO:0071108) | 2.59336868 |
| 62 | response to muramyl dipeptide (GO:0032495) | 2.58936792 |
| 63 | neutrophil mediated immunity (GO:0002446) | 2.58535146 |
| 64 | regulation of defense response to virus by host (GO:0050691) | 2.58460146 |
| 65 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.56728931 |
| 66 | regulation of telomere maintenance (GO:0032204) | 2.56391809 |
| 67 | peptidyl-lysine methylation (GO:0018022) | 2.55958546 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 2.55378328 |
| 69 | positive T cell selection (GO:0043368) | 2.54481542 |
| 70 | histone lysine methylation (GO:0034968) | 2.53397601 |
| 71 | peptidyl-lysine trimethylation (GO:0018023) | 2.53108683 |
| 72 | positive regulation of mast cell degranulation (GO:0043306) | 2.53081598 |
| 73 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53081598 |
| 74 | tolerance induction (GO:0002507) | 2.52796959 |
| 75 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.51355855 |
| 76 | mannose metabolic process (GO:0006013) | 2.51224454 |
| 77 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.50742564 |
| 78 | regulation of mast cell degranulation (GO:0043304) | 2.50338768 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49704151 |
| 80 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.49632533 |
| 81 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.49446203 |
| 82 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.49223508 |
| 83 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.48471192 |
| 84 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.48471192 |
| 85 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.48241438 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.48032177 |
| 87 | regulation of granulocyte differentiation (GO:0030852) | 2.47441751 |
| 88 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.47166849 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.46717610 |
| 90 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.46086315 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45855870 |
| 92 | indole-containing compound catabolic process (GO:0042436) | 2.45688249 |
| 93 | indolalkylamine catabolic process (GO:0046218) | 2.45688249 |
| 94 | tryptophan catabolic process (GO:0006569) | 2.45688249 |
| 95 | positive regulation of histone deacetylation (GO:0031065) | 2.44876826 |
| 96 | meiotic chromosome segregation (GO:0045132) | 2.44464925 |
| 97 | alpha-beta T cell differentiation (GO:0046632) | 2.44264378 |
| 98 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.44194516 |
| 99 | germinal center formation (GO:0002467) | 2.43027135 |
| 100 | histone H4-K5 acetylation (GO:0043981) | 2.41655762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79255756 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.71352661 |
| 3 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.52713435 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13992305 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.07712922 |
| 6 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.95742059 |
| 7 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.70522929 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.46083118 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37934850 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.33730019 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.26920560 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.15820976 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15129978 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.14368026 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07016123 |
| 16 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04666238 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.92777257 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.92281186 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88886832 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84589271 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.82925245 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 1.82461645 |
| 23 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.82197937 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80602065 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80525113 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78999752 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 1.75029392 |
| 28 | GATA3_26560356_Chip-Seq_TH2_Human | 1.74437591 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.72734294 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.67220683 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64852936 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63182876 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63169705 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61349791 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61085442 |
| 36 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.57558531 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56404480 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54015154 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53546045 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53374134 |
| 41 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.53243098 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.52362481 |
| 43 | * MAF_26560356_Chip-Seq_TH1_Human | 1.51654175 |
| 44 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46913845 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46889876 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44819137 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41907540 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39820003 |
| 49 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35769975 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35236714 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33615002 |
| 52 | ERA_21632823_ChIP-Seq_H3396_Human | 1.32044257 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31567218 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31150620 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31012147 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30435768 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30199658 |
| 58 | P300_27268052_Chip-Seq_Bcells_Human | 1.29683639 |
| 59 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.27652560 |
| 60 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.25837217 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25819852 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24152056 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20613071 |
| 64 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.16392038 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.16193926 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15622213 |
| 67 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14799408 |
| 68 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14786281 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12128996 |
| 70 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12073612 |
| 71 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.10633608 |
| 72 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.10382679 |
| 73 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.08793239 |
| 74 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.08644378 |
| 75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06826055 |
| 76 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05899669 |
| 77 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05499941 |
| 78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04777091 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04498494 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03906480 |
| 81 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02617123 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01623693 |
| 83 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01466751 |
| 84 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00654248 |
| 85 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00055125 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99702079 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99332595 |
| 88 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.99020579 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98600961 |
| 90 | * BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.97516311 |
| 91 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97025122 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94075993 |
| 93 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92796498 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91900950 |
| 95 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.91686857 |
| 96 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90976926 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89300706 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89005480 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88804192 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88804192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 2.68211712 |
| 2 | MP0001800_abnormal_humoral_immune | 2.57776321 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 2.51153552 |
| 4 | MP0003724_increased_susceptibility_to | 2.50550748 |
| 5 | MP0005671_abnormal_response_to | 2.44514930 |
| 6 | MP0003303_peritoneal_inflammation | 2.43212995 |
| 7 | MP0009278_abnormal_bone_marrow | 2.42447814 |
| 8 | MP0005387_immune_system_phenotype | 2.32407491 |
| 9 | MP0001790_abnormal_immune_system | 2.32407491 |
| 10 | MP0003787_abnormal_imprinting | 2.31900837 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.27625133 |
| 12 | MP0002132_abnormal_respiratory_system | 2.25895951 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.23544333 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.16755962 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.16755962 |
| 16 | MP0002723_abnormal_immune_serum | 2.16447854 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.05053781 |
| 18 | MP0003646_muscle_fatigue | 2.04893005 |
| 19 | MP0008057_abnormal_DNA_replication | 1.99056532 |
| 20 | MP0000685_abnormal_immune_system | 1.98995473 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.97581456 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.90168482 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.83500236 |
| 24 | MP0001819_abnormal_immune_cell | 1.81805564 |
| 25 | MP0002419_abnormal_innate_immunity | 1.73086251 |
| 26 | MP0000716_abnormal_immune_system | 1.69317778 |
| 27 | MP0002398_abnormal_bone_marrow | 1.68677818 |
| 28 | MP0005025_abnormal_response_to | 1.68320635 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.66477683 |
| 30 | MP0008995_early_reproductive_senescence | 1.66469168 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.62667655 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.61460397 |
| 33 | MP0005167_abnormal_blood-brain_barrier | 1.61318937 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.61178881 |
| 35 | MP0001873_stomach_inflammation | 1.59576316 |
| 36 | MP0002405_respiratory_system_inflammati | 1.56159679 |
| 37 | MP0009785_altered_susceptibility_to | 1.55678423 |
| 38 | MP0009764_decreased_sensitivity_to | 1.55011413 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.49813053 |
| 40 | MP0004147_increased_porphyrin_level | 1.48482917 |
| 41 | MP0008058_abnormal_DNA_repair | 1.46064475 |
| 42 | MP0002722_abnormal_immune_system | 1.46000342 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.42976554 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.40800763 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.36274907 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.34038331 |
| 47 | MP0002429_abnormal_blood_cell | 1.33319167 |
| 48 | MP0002928_abnormal_bile_duct | 1.28682698 |
| 49 | MP0004142_abnormal_muscle_tone | 1.27085752 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.24386132 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.22525029 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.20502917 |
| 53 | MP0005310_abnormal_salivary_gland | 1.18918531 |
| 54 | MP0001764_abnormal_homeostasis | 1.16942831 |
| 55 | MP0004043_abnormal_pH_regulation | 1.15135776 |
| 56 | MP0001661_extended_life_span | 1.15011970 |
| 57 | MP0008872_abnormal_physiological_respon | 1.14038601 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.10423398 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.08405102 |
| 60 | MP0003195_calcinosis | 1.07598196 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.05268574 |
| 62 | MP0003121_genomic_imprinting | 1.04179011 |
| 63 | MP0008469_abnormal_protein_level | 1.03248927 |
| 64 | MP0003828_pulmonary_edema | 1.01025202 |
| 65 | MP0009115_abnormal_fat_cell | 0.99733348 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98593507 |
| 67 | MP0002332_abnormal_exercise_endurance | 0.96809722 |
| 68 | MP0001919_abnormal_reproductive_system | 0.96198172 |
| 69 | MP0005266_abnormal_metabolism | 0.94651777 |
| 70 | MP0002102_abnormal_ear_morphology | 0.94262619 |
| 71 | MP0001986_abnormal_taste_sensitivity | 0.93888844 |
| 72 | MP0004130_abnormal_muscle_cell | 0.93777183 |
| 73 | MP0004947_skin_inflammation | 0.91351771 |
| 74 | MP0005448_abnormal_energy_balance | 0.90430031 |
| 75 | MP0004381_abnormal_hair_follicle | 0.88396385 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 0.84847743 |
| 77 | MP0006082_CNS_inflammation | 0.84372589 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.83893079 |
| 79 | MP0001663_abnormal_digestive_system | 0.83560058 |
| 80 | MP0005334_abnormal_fat_pad | 0.82002440 |
| 81 | MP0009840_abnormal_foam_cell | 0.79590511 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78185808 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.76769215 |
| 84 | MP0010155_abnormal_intestine_physiology | 0.76158250 |
| 85 | MP0008260_abnormal_autophagy | 0.73601223 |
| 86 | MP0004742_abnormal_vestibular_system | 0.73554872 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.72904686 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.72200050 |
| 89 | MP0002009_preneoplasia | 0.67247929 |
| 90 | MP0000371_diluted_coat_color | 0.66092895 |
| 91 | MP0003698_abnormal_male_reproductive | 0.65820913 |
| 92 | MP0001853_heart_inflammation | 0.64431905 |
| 93 | MP0005389_reproductive_system_phenotype | 0.63679316 |
| 94 | MP0000778_abnormal_nervous_system | 0.63205233 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.62684275 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 0.60988934 |
| 97 | MP0000015_abnormal_ear_pigmentation | 0.60964587 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.60314187 |
| 99 | MP0005410_abnormal_fertilization | 0.59024899 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.58312330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protruding tongue (HP:0010808) | 3.64660463 |
| 2 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48156838 |
| 3 | Optic neuritis (HP:0100653) | 3.25122741 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.25122741 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 3.20677121 |
| 6 | Recurrent fungal infections (HP:0002841) | 2.97662174 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.96689809 |
| 8 | Stomatitis (HP:0010280) | 2.96590787 |
| 9 | Eczematoid dermatitis (HP:0000976) | 2.90505165 |
| 10 | Hypoplastic iliac wings (HP:0002866) | 2.87695429 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 2.86644458 |
| 12 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.79290152 |
| 13 | Myositis (HP:0100614) | 2.76439595 |
| 14 | Orchitis (HP:0100796) | 2.75996293 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73431648 |
| 16 | Hyperventilation (HP:0002883) | 2.69917964 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60076538 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60076538 |
| 19 | Congenital stationary night blindness (HP:0007642) | 2.58749024 |
| 20 | Attenuation of retinal blood vessels (HP:0007843) | 2.56922277 |
| 21 | Encephalitis (HP:0002383) | 2.51901347 |
| 22 | Lissencephaly (HP:0001339) | 2.49076467 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.48950756 |
| 24 | Absent speech (HP:0001344) | 2.45200351 |
| 25 | IgG deficiency (HP:0004315) | 2.43108147 |
| 26 | Pustule (HP:0200039) | 2.41048278 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 2.38410012 |
| 28 | Stomach cancer (HP:0012126) | 2.37466904 |
| 29 | Pancreatic cysts (HP:0001737) | 2.35873959 |
| 30 | Widely spaced teeth (HP:0000687) | 2.30729188 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 2.28984585 |
| 32 | Clumsiness (HP:0002312) | 2.27807042 |
| 33 | Macroglossia (HP:0000158) | 2.27645516 |
| 34 | Genetic anticipation (HP:0003743) | 2.27403935 |
| 35 | Molar tooth sign on MRI (HP:0002419) | 2.24486303 |
| 36 | Abnormality of midbrain morphology (HP:0002418) | 2.24486303 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.23486455 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.22800286 |
| 39 | Keratoconjunctivitis (HP:0001096) | 2.22139616 |
| 40 | Abnormality of the fingertips (HP:0001211) | 2.20954927 |
| 41 | Abnormal protein glycosylation (HP:0012346) | 2.15310645 |
| 42 | Abnormal glycosylation (HP:0012345) | 2.15310645 |
| 43 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.15310645 |
| 44 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.15310645 |
| 45 | Broad alveolar ridges (HP:0000187) | 2.12765657 |
| 46 | Keratoconjunctivitis sicca (HP:0001097) | 2.12281092 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.12209628 |
| 48 | Bile duct proliferation (HP:0001408) | 2.12002340 |
| 49 | Abnormal biliary tract physiology (HP:0012439) | 2.12002340 |
| 50 | Vacuolated lymphocytes (HP:0001922) | 2.11796219 |
| 51 | Abnormality of T cells (HP:0002843) | 2.11617561 |
| 52 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08846407 |
| 53 | Abnormality of the renal collecting system (HP:0004742) | 2.08506608 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.06475737 |
| 55 | Recurrent viral infections (HP:0004429) | 2.05425357 |
| 56 | Increased IgE level (HP:0003212) | 2.04146414 |
| 57 | Recurrent skin infections (HP:0001581) | 2.00481893 |
| 58 | Type II lissencephaly (HP:0007260) | 1.99575849 |
| 59 | Duplicated collecting system (HP:0000081) | 1.96183590 |
| 60 | Chronic hepatic failure (HP:0100626) | 1.96137217 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 1.95171205 |
| 62 | True hermaphroditism (HP:0010459) | 1.95043867 |
| 63 | Meningitis (HP:0001287) | 1.93882459 |
| 64 | Deep palmar crease (HP:0006191) | 1.91437684 |
| 65 | Alveolar cell carcinoma (HP:0006519) | 1.91246325 |
| 66 | Abnormality of DNA repair (HP:0003254) | 1.90843202 |
| 67 | Abnormality of T cell number (HP:0011839) | 1.90295452 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 1.89995455 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89655207 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 1.88525443 |
| 71 | Nephronophthisis (HP:0000090) | 1.88154604 |
| 72 | Brushfield spots (HP:0001088) | 1.86901765 |
| 73 | Abnormality of dental color (HP:0011073) | 1.86258542 |
| 74 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85389497 |
| 75 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.84950212 |
| 76 | Polydipsia (HP:0001959) | 1.84346146 |
| 77 | Abnormal drinking behavior (HP:0030082) | 1.84346146 |
| 78 | Agammaglobulinemia (HP:0004432) | 1.83610921 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.82022740 |
| 80 | Abnormality of the pons (HP:0007361) | 1.81754172 |
| 81 | Hypochromic anemia (HP:0001931) | 1.81559465 |
| 82 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81061645 |
| 83 | Failure to thrive in infancy (HP:0001531) | 1.80567244 |
| 84 | Progressive cerebellar ataxia (HP:0002073) | 1.80041074 |
| 85 | T lymphocytopenia (HP:0005403) | 1.79639130 |
| 86 | Abnormality of eosinophils (HP:0001879) | 1.79537796 |
| 87 | Recurrent sinusitis (HP:0011108) | 1.78945387 |
| 88 | Pachygyria (HP:0001302) | 1.74235401 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 1.72631435 |
| 90 | Thyroiditis (HP:0100646) | 1.70575617 |
| 91 | Abnormality of macrophages (HP:0004311) | 1.70092630 |
| 92 | Basal cell carcinoma (HP:0002671) | 1.68800597 |
| 93 | Impulsivity (HP:0100710) | 1.67057401 |
| 94 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.66194027 |
| 95 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.66194027 |
| 96 | Abnormality of glycolipid metabolism (HP:0010969) | 1.66194027 |
| 97 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.66152874 |
| 98 | Hypoplasia of the pons (HP:0012110) | 1.65865754 |
| 99 | Adactyly (HP:0009776) | 1.65535088 |
| 100 | Vasculitis (HP:0002633) | 1.65334012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK2 | 3.95658449 |
| 2 | EPHA3 | 2.97843019 |
| 3 | FRK | 2.63541486 |
| 4 | CDK12 | 2.47417903 |
| 5 | TXK | 2.42247274 |
| 6 | MAP4K1 | 2.28901972 |
| 7 | TRIM28 | 2.13039233 |
| 8 | RIPK4 | 1.89465190 |
| 9 | IRAK1 | 1.88976993 |
| 10 | MARK3 | 1.87034110 |
| 11 | TAOK3 | 1.85303697 |
| 12 | IRAK4 | 1.78510532 |
| 13 | BCKDK | 1.72373759 |
| 14 | WNK3 | 1.59848232 |
| 15 | MAP3K11 | 1.59790939 |
| 16 | ADRBK2 | 1.58300450 |
| 17 | MAP2K7 | 1.57784245 |
| 18 | TLK1 | 1.55237679 |
| 19 | IKBKE | 1.53918997 |
| 20 | DYRK1B | 1.51450682 |
| 21 | BMPR1B | 1.50934127 |
| 22 | IKBKB | 1.47188429 |
| 23 | MAP2K4 | 1.42716263 |
| 24 | CHUK | 1.41207877 |
| 25 | MAP3K4 | 1.39063751 |
| 26 | SIK3 | 1.37435761 |
| 27 | BLK | 1.35903999 |
| 28 | BTK | 1.31273196 |
| 29 | BRD4 | 1.28729309 |
| 30 | MAP3K14 | 1.25382473 |
| 31 | PIM1 | 1.23512718 |
| 32 | MAP4K2 | 1.19194677 |
| 33 | MAP3K6 | 1.16902045 |
| 34 | TNK2 | 1.14750762 |
| 35 | TRPM7 | 1.12460504 |
| 36 | TYK2 | 1.11562023 |
| 37 | SYK | 1.09672545 |
| 38 | DAPK2 | 1.04696386 |
| 39 | PINK1 | 1.04414904 |
| 40 | MAP3K7 | 1.03898172 |
| 41 | MAP3K10 | 1.02520561 |
| 42 | GRK6 | 1.01554326 |
| 43 | AKT3 | 1.01449606 |
| 44 | CSF1R | 0.98263387 |
| 45 | TBK1 | 0.97435684 |
| 46 | CAMK1D | 0.97010316 |
| 47 | BMPR2 | 0.96962429 |
| 48 | NLK | 0.94051828 |
| 49 | JAK2 | 0.92942887 |
| 50 | HIPK2 | 0.92290647 |
| 51 | KIT | 0.89332409 |
| 52 | JAK3 | 0.88675887 |
| 53 | ZAK | 0.88329770 |
| 54 | CAMK1G | 0.87978757 |
| 55 | MAPK13 | 0.87614820 |
| 56 | BCR | 0.85410473 |
| 57 | LCK | 0.83873794 |
| 58 | MARK2 | 0.83784634 |
| 59 | MAP3K5 | 0.83288701 |
| 60 | WNK4 | 0.83159669 |
| 61 | HCK | 0.82771917 |
| 62 | EPHB1 | 0.82282246 |
| 63 | ZAP70 | 0.81595570 |
| 64 | ITK | 0.81497177 |
| 65 | ERN1 | 0.77902494 |
| 66 | LYN | 0.77897023 |
| 67 | CAMKK2 | 0.76253811 |
| 68 | PDK2 | 0.73324238 |
| 69 | EEF2K | 0.73274561 |
| 70 | FES | 0.73154671 |
| 71 | PRKCZ | 0.72443826 |
| 72 | ACVR1B | 0.71661006 |
| 73 | MATK | 0.70306595 |
| 74 | TESK2 | 0.70079434 |
| 75 | RPS6KA6 | 0.69722695 |
| 76 | TEC | 0.65640347 |
| 77 | STK11 | 0.64583709 |
| 78 | RPS6KA5 | 0.60574223 |
| 79 | MAP3K1 | 0.60050701 |
| 80 | CSK | 0.58762866 |
| 81 | GRK7 | 0.58723393 |
| 82 | DYRK2 | 0.58179992 |
| 83 | PRKAA1 | 0.57189170 |
| 84 | CAMKK1 | 0.54685398 |
| 85 | PIM2 | 0.50951258 |
| 86 | PRKD2 | 0.50592736 |
| 87 | RPS6KC1 | 0.48888234 |
| 88 | RPS6KL1 | 0.48888234 |
| 89 | RPS6KA1 | 0.48022225 |
| 90 | CAMK4 | 0.46611699 |
| 91 | MAP2K2 | 0.45638203 |
| 92 | KSR1 | 0.45334904 |
| 93 | MAP2K6 | 0.43473465 |
| 94 | MAPK15 | 0.43393755 |
| 95 | PDK1 | 0.42028840 |
| 96 | MAPKAPK3 | 0.41597905 |
| 97 | PRKCQ | 0.41396740 |
| 98 | DYRK3 | 0.41016830 |
| 99 | FGR | 0.39639025 |
| 100 | PRKCI | 0.39587281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.84433498 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.66747006 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.62857644 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.56017173 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.38483004 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28608702 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21048327 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.16300425 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.13228540 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02984510 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.02268041 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98010206 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92175563 |
| 14 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.84733681 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80294975 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74107238 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73011614 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.72899615 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.72542562 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67604222 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.60107931 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57856881 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52962902 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48217868 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.47499202 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36258715 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35040280 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27206913 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26624430 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.26559452 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24477036 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.22299382 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20136285 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17409958 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.14992180 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.13504731 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12975555 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.12471983 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.09607417 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09599196 |
| 41 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07002498 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.05562511 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03420407 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00600251 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99696453 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94739333 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.90754501 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90678207 |
| 49 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85975637 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.85973602 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.81152461 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80364336 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79803422 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79219565 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78928270 |
| 56 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78917647 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78798330 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76641858 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.76491885 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75836875 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.75480817 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.75469650 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75120035 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.74815127 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74603554 |
| 66 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74101224 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.73810074 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73461997 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73190576 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71403956 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70687398 |
| 72 | Phagosome_Homo sapiens_hsa04145 | 0.69750763 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67245436 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.67088268 |
| 75 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66817497 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60840762 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59426551 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57940857 |
| 79 | Homologous recombination_Homo sapiens_hsa03440 | 0.53241681 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52868213 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52377668 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51730102 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51710680 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.50460948 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48963731 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47305833 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44427640 |
| 88 | Taste transduction_Homo sapiens_hsa04742 | 0.44292110 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44138964 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43637100 |
| 91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41683647 |
| 92 | Morphine addiction_Homo sapiens_hsa05032 | 0.41679909 |
| 93 | Long-term depression_Homo sapiens_hsa04730 | 0.41067112 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.39984267 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39440452 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.39224894 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38417966 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.36779944 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36549405 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33873025 |

